Pharmaceutical manufacturing has a problem that doesn't affect most industries: the places where you most need real time data are often the places you can't take a standard device. API synthesis areas, granulation suites, solvent handling zones. All classified, all off limits to anything that isn't certified for the explosive atmosphere present.
So the industry has been forced to get specific about what a certified device actually needs to do. Not just "can it survive the environment" but "can it run the workflows that matter." That's what this post covers: the field workflows that explosion proof and intrinsically safe devices need to support in pharmaceutical manufacturing, and what the hardware and software requirements look like in practice.
If there's one workflow that justifies the cost of deploying certified devices on the production floor, it's electronic batch record capture. Batch Manufacturing Records are legally mandated documents in pharmaceutical production. Every weight, temperature, process step, and operator sign off has to be recorded for each lot produced. Historically, that meant paper. Paper in cleanrooms, paper near solvents, paper that gets scanned and filed and reviewed by quality teams weeks after the batch has shipped.
Paper also carries a transcription error rate that studies put at up to 50% of all batch record problems. A field worker writes down 4.8 kg when they meant 48 kg, and a quality reviewer catches it three weeks later. By then, you're looking at an investigation, possible batch rejection, and a deviation report that takes 80 hours to close.
Mobile devices in Zone 1 and Zone 2 environments change that equation. When an operator's device connects directly to a Bluetooth scale or inline sensor, the reading populates the batch record without human transcription. The software can enforce sequence: step A requires a verified sign off before step B is visible, which builds compliance into the process rather than checking for it afterward.
For this to work, the hardware requirements are demanding. The device needs to hold ATEX Zone 1 certification as a minimum, covering Gas Group IIC and a T4 temperature class or better. That combination covers the volatile solvents common in API synthesis, including ethyl ether, which has a relatively low auto ignition temperature of 160°C. A device rated to T4 limits surface temperature to 135°C and stays within that safety margin.
The device also needs Bluetooth connectivity that functions reliably without creating an ignition risk, and enough processing capability to run the eBMR software while maintaining a continuous sensor connection. In 2026, these platforms are increasingly connecting to private 5G networks rather than Wi-Fi. Dense pharmaceutical facilities with metal-heavy infrastructure cause Wi-Fi interference that breaks connectivity at the worst moments. Private 5G handles that problem, and it's fast becoming the standard for new deployments.
Batch record capture gets most of the attention, but material verification is where mobile devices prevent the problems that are hardest to fix: wrong ingredients.
A pharmaceutical production batch rejected because of contamination or ingredient misidentification doesn't just cost the batch. It triggers an investigation, a regulatory notification in some cases, and a root cause analysis that consumes significant quality team time. The root cause is often simple: a container was picked from the wrong location, or a batch of raw material was used past its expiry date because nobody checked.
An operator with a Zone 1 certified device and an integrated barcode or QR scanner can verify every container at the point of use. The scan pulls identity, potency, expiry date, and approved supplier status from the ERP or MES system in real time. If anything doesn't match the Master Batch Record, the system flags it before the container is opened. That's a straightforward workflow, but its reliability depends on the device working in the conditions present in a pharmaceutical production area.
IP69K certification matters here more than people initially expect. IP68 covers immersion, which sounds thorough until a facility runs a high pressure hot washdown and the seals fail. IP69K certifies the device against water jets at up to 1450 psi and 80°C, which is the relevant test for pharmaceutical production environments that undergo regular CIP (clean in place) or manual sterilization cleaning cycles.
Chemical resistance matters too. Devices and their cases need to survive repeated exposure to 70% isopropyl alcohol, which is used constantly as a surface disinfectant. Facilities with isolators may also run vaporized hydrogen peroxide (VHP) bio-decontamination cycles. TPU cases tend to degrade under VHP exposure. Polycarbonate handles it significantly better, which is why the case material matters as much as the device underneath.
Standard operating procedures have always been the operational backbone of pharmaceutical manufacturing. They're also historically one of the biggest points of failure. Printed SOP binders go out of date. Pages get damaged or separated. Operators working infrequent tasks reach for the binder and find a version that was superseded eighteen months ago.
Mobile devices in hazardous zones allow quality teams to push updated SOPs directly to field devices the moment they're approved. An operator working a changeover on a filling line sees the current version of the procedure on their screen, not a laminated card from three years ago. If the SOP includes a video demonstration of a complex equipment assembly step, they can watch it on the device, at the machine, at the moment they need it.
This sounds simple but it requires real enterprise mobile device management (MDM) infrastructure. The devices need to operate within a managed software environment where the quality team controls what versions of documents are live and which have been retired. That governance structure is part of what regulators look at during audits.
The trend through 2026 is toward AI-assisted work instructions. Rather than a static procedure that lists steps, the system can analyze real time process data from connected sensors and flag steps where the current conditions differ from the procedure's expected parameters. The operator gets a prompt to verify, not just a static checklist. That's a meaningful change in how errors get caught.
The gap between the production floor and the quality office has always created friction. A field technician encounters an anomaly during a batch. They describe it to a quality engineer over the phone. The quality engineer makes a decision based on a verbal description. That's a lot of room for misunderstanding in a context where the consequences of a wrong call can be serious.
Explosion proof and intrinsically safe devices with cameras and real time communication capability close that gap in a way that telephone calls simply cannot. A field operator uses their Zone 1 certified device to share a live video feed from inside the hazardous area with an office based expert who can see exactly what the operator sees. Annotations, instructions, and decisions flow back in real time.
Microsoft Teams has become the default platform for this in many pharmaceutical facilities, with integrations designed for field use. Platforms like RealWear extend this to hands free operation for tasks where the operator needs both hands free. The office expert joins the session through a short code, sees the live view, and can talk the operator through a decision or a corrective action without anyone having to leave their zone.
This same capability has changed how Remote Factory Acceptance Tests work. New equipment commissioned at a vendor's facility can be tested with the customer's engineering and quality teams watching via mobile cameras from their own offices, sometimes from a different country. The FDA and other regulatory bodies have recognized Remote Regulatory Assessments as a formal oversight mechanism, which means having a mobile-ready facility is no longer just an operational convenience.
The hardware requirements for reliable remote collaboration in hazardous zones are worth noting. The device needs sufficient camera quality to give a useful picture of machinery, labeling, or process conditions. It needs a stable network connection, which in 2026 increasingly means 5G rather than Wi-Fi. And it needs long enough battery life to sustain a session through a complex troubleshooting exercise, often several hours in a hot, busy production environment.
Pharmaceutical production lines run on tight schedules. Unplanned downtime during a batch can mean the whole lot is compromised. Maintenance teams in hazardous zones need to inspect and service equipment in conditions where standard devices can't operate.
Certified mobile devices in Zone 1 or Zone 2 environments allow maintenance technicians to access live equipment data through connected sensors while physically inspecting the asset. Vibration readings, thermal data, motor performance metrics: all of it accessible on the device while the technician is standing next to the machine. That combination of physical presence and live data makes inspections faster and more accurate than a tech working from a printed work order and their own judgment.
Through 2026, the shift is toward what's being described as agentic AI in maintenance workflows. The device doesn't just display current sensor data; the underlying system analyzes historical patterns and surfaces early warning signals. A technician's work order for a routine inspection now comes with context: "This pump has shown increasing vibration variance over the last six weeks. Check the bearing." That kind of pre-briefing changes the quality of the inspection before the technician even sets foot on the floor.
For Zone 1 maintenance environments, the ATEX requirements apply in full. Gas Group IIC T4 remains the standard to aim for in API synthesis areas. For dust zones common in granulation and milling, the equivalent Zone 21 certification covers the risk profile present during normal operation.
Pharmaceutical companies get audited. By the FDA, by the EMA, by customers, by partners. The audit process requires quick access to batch records, deviation reports, change controls, and SOPs. In a paper based system, retrieving a complete batch record for a lot produced eighteen months ago can take days. Quality teams spend those days scanning, collating, and manually indexing documents.
Mobile devices connected to a central document management system allow field teams to generate and close documentation at the point of work, in real time. When an audit comes, records are already structured, time-stamped, and digitally signed. The retrieval time drops from days to minutes.
July 2026 adds a specific compliance pressure for manufacturers producing both human and veterinary medicines. The EU's split of human and veterinary GMP requirements into separate frameworks means companies running both product types need to manage two distinct documentation systems, two sets of SOPs, and potentially two different facility classifications. Managing that on paper is genuinely difficult. Managing it through a mobile connected MES, where records are tagged to the correct regulatory framework at the point of capture, is the practical solution most facilities are moving toward.
The workflows above don't each have a separate hardware wishlist. They largely share the same baseline: ATEX Zone 1 with Gas Group IIC and T4 minimum, IP69K for washdown resistance, polycarbonate or equivalent housing that survives IPA and VHP, reliable 5G connectivity, a camera good enough for live remote collaboration, and battery life that holds through a full shift. Get those right and the device can support all of it.
What's changing through 2026 is the software stack sitting on top of that hardware. The device is increasingly an access point for a connected ecosystem: MES, ERP, LIMS, MDM, and communication platforms that need to work together without the field operator having to think about it. The ex-proof case isn't just a protective shell. It's what makes it possible to bring a capable enterprise device into a Zone 1 environment without stripping out the functionality that makes it worth deploying.
What ATEX zone certification do mobile devices need in pharmaceutical manufacturing? Most pharmaceutical production areas, particularly those involving API synthesis with volatile solvents, require Zone 1 certification for gases. Dust areas in granulation and milling typically require Zone 21. For maximum flexibility across a facility, a device or case rated to ATEX Zone 1, Gas Group IIC, T4 covers the widest range of pharmaceutical solvents including ethyl ether.
What IP rating do explosion proof devices need in pharmaceutical production? IP68 covers immersion but is insufficient for facilities that run high pressure hot washdowns. IP69K is the appropriate rating for pharmaceutical production environments, certifying against water jets at up to 1450 psi and 80°C.
What disinfectants do explosion proof phone cases need to be resistant to? Pharmaceutical environments typically use 70% isopropyl alcohol (IPA) as a routine surface disinfectant. Facilities with isolators may also run vaporized hydrogen peroxide (VHP) bio-decontamination. Cases with polycarbonate housings perform significantly better under VHP than TPU-based cases, which can degrade and compromise the device seal.